Search alternatives:
agents decrease » largest decrease (Expand Search)
marked decrease » marked increase (Expand Search)
derived agents » derived genes (Expand Search), derived fragments (Expand Search)
large decrease » larger decrease (Expand Search), large increases (Expand Search), large degree (Expand Search)
agents decrease » largest decrease (Expand Search)
marked decrease » marked increase (Expand Search)
derived agents » derived genes (Expand Search), derived fragments (Expand Search)
large decrease » larger decrease (Expand Search), large increases (Expand Search), large degree (Expand Search)
-
1
-
2
-
3
-
4
-
5
-
6
Discovery of Novel Coumarin Pleuromutilin Derivatives as Potent Anti-MRSA Agents
Published 2024Subjects: “…novel pleuromutilin derivatives…”
-
7
Discovery of Novel Coumarin Pleuromutilin Derivatives as Potent Anti-MRSA Agents
Published 2024Subjects: “…novel pleuromutilin derivatives…”
-
8
Discovery of Novel Coumarin Pleuromutilin Derivatives as Potent Anti-MRSA Agents
Published 2024Subjects: “…novel pleuromutilin derivatives…”
-
9
-
10
-
11
-
12
-
13
Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer
Published 2024“…Mechanistically, compound <b>E35</b> markedly decreased the expression of Skp2, as well as increased the expression of its substrates p21 and p27. …”
-
14
Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer
Published 2024“…Mechanistically, compound <b>E35</b> markedly decreased the expression of Skp2, as well as increased the expression of its substrates p21 and p27. …”
-
15
Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer
Published 2024“…Mechanistically, compound <b>E35</b> markedly decreased the expression of Skp2, as well as increased the expression of its substrates p21 and p27. …”
-
16
Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer
Published 2024“…Mechanistically, compound <b>E35</b> markedly decreased the expression of Skp2, as well as increased the expression of its substrates p21 and p27. …”
-
17
Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer
Published 2024“…Mechanistically, compound <b>E35</b> markedly decreased the expression of Skp2, as well as increased the expression of its substrates p21 and p27. …”
-
18
-
19
-
20